Results 61 to 70 of about 6,415 (210)

The Epidemiology and Infection Control of Candida Auris in Shanghai

Mycoses, Volume 69, Issue 4, April 2026.
ABSTRACT Background Candida auris is a globally emerging multidrug‐resistant fungus. Its dissemination is driven by patient movement and asymptomatic carriers. However, molecular epidemiological studies linking imported cases to local strains in large metropolitan areas remain limited.
Mingjing Wei, Jian Guo, Li Li, Junhao Zhu, Yuyuan Xue, Guo Chen, Fan Yang, Wenjuan Wu, Min Zhu   +8 more
wiley   +1 more source

Clinical Outcomes of Intra‐Abdominal Candidiasis by Initial Antifungal Therapy

Mycoses, Volume 69, Issue 3, March 2026.
ABSTRACT Background Intra‐abdominal candidiasis (IAC) is a severe and heterogeneous infection associated with significant morbidity and mortality. Objectives To evaluate outcomes of IAC according to initial antifungal therapy and to identify predictors of persistent infection and 30‐day mortality.
M. Albanell‐Fernández, A. Vergara, F. Marco, S. Herrera, M. Tuset, A. Soriano, M. Bodro   +6 more
wiley   +1 more source

Anidulafungin compared with fluconazole for treatment of candidemia and other forms of invasive candidiasis caused by Candida albicans: a multivariate analysis of factors associated with improved outcome

BMC Infectious Diseases, 2011
Background Candida albicans is the most common cause of candidemia and other forms of invasive candidiasis. Systemic infections due to C. albicans exhibit good susceptibility to fluconazole and echinocandins.
Reisman Arlene L, Schlamm Haran T, Kett Daniel H, Pappas Peter G, Rotstein Coleman, Shorr Andrew F, Reboli Annette C, Biswas Pinaki, Walsh Thomas J   +8 more
doaj   +1 more source

Stability of Anidulafungin in Concentrated Pharmaceutical Solution

, 2017
Background Currently, the reconstitution instructions in the package insert indicate that 100 mg of anidulafungin powder is to be dissolved in 30 ml of sterile water for injection and this reconstituted solution is to be further mixed ...
Siang Fei Yeoh, Chi Lui Ho, Chien Yap, Yin Shan Lim   +3 more
core   +1 more source

Susceptibility of the Candida haemulonii Complex to Echinocandins: Focus on Both Planktonic and Biofilm Life Styles and a Literature Review

Journal of Fungi, 2020
Candida haemulonii complex (C. haemulonii, C. duobushaemulonii and C. haemulonii var. vulnera) is well-known for its resistance profile to different available antifungal drugs.
Lívia S. Ramos, Laura N. Silva, Marta H. Branquinha, André L. S. Santos   +3 more
doaj   +1 more source

Antiviral activity and mechanism of the antifungal drug, anidulafungin, suggesting its potential to promote treatment of viral diseases

BMC Medicine, 2022
Background The severe fever with thrombocytopenia syndrome disease (SFTS), caused by the novel tick-borne SFTS virus (SFTSV), was listed among the top 10 priority infectious disease by World Health Organization due to the high fatality rate of 5–30% and ...
Shu Shen, Yaxian Zhang, Zhiyun Yin, Qiong Zhu, Jingyuan Zhang, Tiantian Wang, Yaohui Fang, Xiaoli Wu, Yuan Bai, Shiyu Dai, Xijia Liu, Jiayin Jin, Shuang Tang, Jia Liu, Manli Wang, Yu Guo, Fei Deng   +16 more
doaj   +1 more source

Azole Resistance in Candida parapsilosis From Patients With Burns in Mexico: A Genomic and Phylogenetic Analysis

Mycoses, Volume 69, Issue 3, March 2026.
ABSTRACT Background Candida species are common causes of nosocomial infections. Candida parapsilosis has emerged as an important pathogen. Mortality rates associated with invasive C. parapsilosis infections range from 14.5% to 47%, with azole resistance estimated between 4% and 15%.
María de Lourdes García‐Hernández, Luis Ángel Nuñez‐García, Jossue Ortíz‐Álvarez, Marco Antonio Delaye‐Martínez, Marlen Flores‐Huacuja, María del Rocío Vazquez‐Olivares, Luis Fernando Espinosa‐Camacho, Gabriela Delgado‐Sapien, María del Rosario Morales‐Espinosa, Noé Becerra‐Lobato, Rafael Franco‐Cendejas, Elvira Garza‐González, Luis Ostrosky‐Zeichner, Tatiana Chávez‐Heres, Melissa Hernández‐Durán, Luis Esaú López‐Jácome, Claudia Adriana Colín‐Castro   +16 more
wiley   +1 more source

In Vitro Activitiy of Rezafungin in Comparison with Anidulafungin and Caspofungin against Invasive Fungal Isolates (2017 to 2022) in China

Journal of Fungi
The efficacy of different echinocandins is assessed by evaluating the in vitro activity of a novel antifungal, rezafungin, against invasive fungal isolates in comparison with anidulafungin and caspofungin.
Simin Yang, Feifei Wan, Min Zhang, Huiping Lin, Liang Hu, Ziyi Zhou, Dongjiang Wang, Aiping Zhou, Lijun Ni, Jian Guo, Wenjuan Wu   +10 more
doaj   +1 more source

Biocide Response of Candida auris

Mycoses, Volume 69, Issue 3, March 2026.
ABSTRACT Candida auris is an emerging multidrug‐resistant yeast demonstrating remarkable persistence in healthcare environments, contributing to nosocomial transmission and outbreak persistence. Increasing disinfectant failure reports have raised concerns regarding infection control policies, as environmental reservoirs play central roles in its spread.
Sidre Erganis, Ali Ozturk, Elif Ayca Sahin, Ayse Kalkanci   +3 more
wiley   +1 more source

Anidulafungin-Induced Alopecia

Annals of Pharmacotherapy, 2014
Objetive: To report a case of a woman in whom alopecia appeared after several months of treatment with anidulafungin. Case Summary: A 34-year-old woman with chronic femoral osteomyelitis with the presence of persistent suppuration, developed a Candida albicans infection, isolated in the fistula exudate cultures. After initial failures of single therapy
Ruiz-Ramos J, Salavert-Lleti M, Monte-Boquet E, Lorente-Fernández L, Gil-Gómez I, Poveda-Andrés JL   +5 more
openaire   +3 more sources